![](https://www.israelandstuff.com/wp-content/uploads/2016/11/Packaged-medicine-Photo-public-domain--300x174.png)
Neuroderm, the Israeli pharmaceutical company that deals with “next-generation treatments” was just bought for $1.1B in cash by Mitsubishi Tanabe Pharma
By i24NEWS
Israeli pharmaceutical company Neuroderm has been bought out in a massive deal for $1.1 billion by Japan’s Mitsubishi Tanabe Pharma Corp, the company announced on Monday.
The all-cash deal will expand the company’s business overseas, according to Reuters.
![](https://new.israelandstuff.com/wp-content/uploads/2016/08/Medical-student-conducting-research-Photo-TAU’s-Sackler-School-of-Medicine.png)
Medical student conducting research – Photo: Tel Aviv University’s Sackler School of Medicine
NeuroDerm develops drugs and medical devices for central nervous system (CNS) disorders such as Parkinson’s, in which it was the first to develop a key treatment currently used for the disease.
According to the company’s website, they are a clinical-stage pharmaceutical company developing “next-generation treatments.”
View original i24NEWS publication at:
http://www.i24news.tv/en/news/economy/151200-170724-japan-s-mitsubishi-tanabe-pharma-buys-israeli-pharmaceutical-company-for-1-1-b